OTC · Financial Statements
Calithera Biosciences, Inc. (CALA) Financial Statements
$0.00
OTC: CALA
Market Cap $487
Overview Financials Dividend Calithera Biosciences, Inc. most recently reported annual revenue of $0, net profit of $-19.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $22.0M $0 $0 $10.0M $0 Operating Profit $-57.0M $-93.0M $-91.0M $-114.0M $-42.0M Net Profit $-51.0M $-86.0M $-89.0M $-115.0M $-19.0M EPS $-28.12 $-36.50 $-26.20 $-31.16 $-7.94 Op Margin -257.4% — — -1172.1% —
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $143.0M $169.0M $126.0M $65.0M $29.0M Total Liabilities $16.0M $26.0M $23.0M $56.0M $8.0M Cash $51.0M $60.0M $107.0M $60.0M $25.0M Borrowings $0 $8.0M $7.0M $3.0M $2.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-65.0M $-79.0M $-84.0M $-66.0M $-44.0M Investing Cash Flow $53.0M $-11.0M $89.0M $8.0M $0 Financing Cash Flow $1.0M $1.0M $1.0M $0 $0 Net Cash Flow $3.0M $9.0M $47.0M $-48.0M $-34.0M Free Cash Flow $-65.0M $-79.0M $-84.0M $-66.0M $-44.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.62 FCF Yield -8981724.85% Quick Ratio 3.60 Interest Coverage 0.00 Return 1Y 0.00% Return 3Y -99.80% Return 5Y —
Screens featuring this stock